课题基金 / 基金详情

Genetic analysis of cell death pathways, drug resistance and oncogenic co-operativity in IL-3 dependent cell lines

Genetic analysis of cell death pathways, drug resistance and oncogenic co-operativity in IL-3 dependent cell lines
IL-3 依赖性细胞系细胞死亡途径、耐药性和致癌协同性的遗传分析
批准号:
nhmrc : 384404
负责人:
A/Pr Paul Ekert
金额:
$29.69万
依托单位国家:
澳大利亚
项目类别:
NHMRC Project Grants
财政年份:
2006
资助国家:
澳大利亚
项目状态:
已结题
起止时间:
2006-01-01 至 2008-12-31

项目摘要

项目成果

A/Pr Paul Ekert的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The ultimate fate of most of our cells is to die by committing suicide, because they are no longer required, are no longer functioning, or are potentially harmful. This normal physiological process is termed apoptosis . Inappropriate apoptosis can contribute to cell loss following heart attacks, stroke or neurodegenerative diseases, such as Alzheimer s or Parkinson s disease. Conversely, when cell death fails to occur, abnormal cells can accumulate and lead to cancer. In addition, because drugs that are used to treat cancer may exert their effect by inducing apoptosis, a failure of this suicide response may cause resistance to chemotherapy. The genes of the apoptosis pathway function either to promote or inhibit cell death. We have found that some genes in the apoptosis pathway allow apoptosis to proceed rapidly, but do not decide the fate of the cell. Other genes are required for a cell to commit to die. If these genes are mutated then apoptosis does not occur and a functional cell may survive. The distinction between cells that decide fate and those that do not is crucial because it is only the genes that decide cell fate that can act as cancer genes, and are valid targets for therapy. We use a model in which apoptosis is caused by removal of a growth factor, using cell lines derived from mice that lack particular genes in the cell death pathway. These cells proliferate normally in the presence of growth factor, and allow us to determine the role of the genes when growth factor is withdrawn. Because these cells are sensitive to chemotherapeutic drugs, we can also determine the contribution these genes make to cancer drug sensitivity. Using this system, we have discovered that Puma, a gene known to be required for apoptosis in response to radiation, is also a critical activator of apoptosis following growth factor withdrawal. We will determine the manner in which Puma is regulated by growth factors, as well as identify and characterise other key components.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Interleukin-3 receptor signaling is a driver of myeloid leukaemia and a significant therapeutic target
  • 批准号:
    nhmrc : GNT1103244
  • 项目类别:
    Project Grants
  • 资助金额:
    $60.2万
  • 财政年份:
    2016
  • 负责人:
    A/Pr Paul Ekert
  • 依托单位:
Interleukin-3 receptor signaling is a driver of myeloid leukaemia and a significant therapeutic target
  • 批准号:
    nhmrc : 1103244
  • 项目类别:
    Project Grants
  • 资助金额:
    $41.28万
  • 财政年份:
    2016
  • 负责人:
    A/Pr Paul Ekert
  • 依托单位:
Does CD123 provide a biological advantage to leukaemia stem cells?
  • 批准号:
    nhmrc : 1048071
  • 项目类别:
    Project Grants
  • 资助金额:
    $43.18万
  • 财政年份:
    2013
  • 负责人:
    A/Pr Paul Ekert
  • 依托单位:
Molecular characterisation of a new survival pathway in haematopoietic cells
国内基金
海外基金
Scalable Learning and Optimization: High-dimensional Models and Online Decision-Making Strategies for Big Data Analysis
Intelligent Patent Analysis for Optimized Technology Stack Selection:Blockchain BusinessRegistry Case Demonstration
  • 批准号:
    --
  • 项目类别:
    外国学者研究基金项目
  • 资助金额:
    --
  • 批准年份:
    2024
  • 负责人:
    USHARANI HAREESH GOVINDARA JAN
  • 依托单位:
利用全基因组关联分析和QTL-seq发掘花生白绢病抗性分子标记
基于SERS纳米标签和光子晶体的单细胞Western Blot定量分析技术研究
  • 批准号:
    31900571
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    24.0万元
  • 批准年份:
    2019
  • 负责人:
    刘兵
  • 依托单位: